Johnson Bryce G, Dang Lan T, Marsh Graham, Roach Allie M, Levine Zebulon G, Monti Anthony, Reyon Deepak, Feigenbaum Lionel, Duffield Jeremy S
Research and Development, Biogen, Cambridge, Massachusetts, USA.
Department of Medicine, University of Washington, Seattle, Washington, USA.
J Clin Invest. 2017 Nov 1;127(11):3954-3969. doi: 10.1172/JCI93817. Epub 2017 Oct 9.
Uromodulin-associated kidney disease (UAKD) is caused by mutations in the uromodulin (UMOD) gene that result in a misfolded form of UMOD protein, which is normally secreted by nephrons. In UAKD patients, mutant UMOD is poorly secreted and accumulates in the ER of distal kidney epithelium, but its role in disease progression is largely unknown. Here, we modeled UMOD accumulation in mice by expressing the murine equivalent of the human UMOD p.Cys148Trp point mutation (UmodC147W/+ mice). Like affected humans, these UmodC147W/+ mice developed spontaneous and progressive kidney disease with organ failure over 24 weeks. Analysis of diseased kidneys and purified UMOD-producing cells revealed early activation of the PKR-like ER kinase/activating transcription factor 4 (PERK/ATF4) ER stress pathway, innate immune mediators, and increased apoptotic signaling, including caspase-3 activation. Unexpectedly, we also detected autophagy deficiency. Human cells expressing UMOD p.Cys147Trp recapitulated the findings in UmodC147W/+ mice, and autophagy activation with mTOR inhibitors stimulated the intracellular removal of aggregated mutant UMOD. Human cells producing mutant UMOD were susceptible to TNF-α- and TRAIL-mediated apoptosis due to increased expression of the ER stress mediator tribbles-3. Blocking TNF-α in vivo with the soluble recombinant fusion protein TNFR:Fc slowed disease progression in UmodC147W/+ mice by reducing active caspase-3, thereby preventing tubule cell death and loss of epithelial function. These findings reveal a targetable mechanism for disease processes involved in UAKD.
尿调节蛋白相关肾病(UAKD)由尿调节蛋白(UMOD)基因突变引起,该突变导致UMOD蛋白错误折叠,而UMOD蛋白通常由肾单位分泌。在UAKD患者中,突变的UMOD分泌不佳并积聚在远端肾上皮的内质网中,但其在疾病进展中的作用很大程度上尚不清楚。在此,我们通过表达与人类UMOD p.Cys148Trp点突变等效的小鼠模型(UmodC147W/+小鼠)来模拟小鼠体内UMOD的积聚。与受影响的人类一样,这些UmodC147W/+小鼠在24周内出现了自发性进行性肾病并伴有器官衰竭。对患病肾脏和纯化的产生UMOD的细胞进行分析发现,蛋白激酶R样内质网激酶/激活转录因子4(PERK/ATF4)内质网应激途径、先天性免疫介质早期激活,以及包括半胱天冬酶-3激活在内的凋亡信号增加。出乎意料的是,我们还检测到自噬缺陷。表达UMOD p.Cys147Trp的人类细胞重现了UmodC147W/+小鼠中的发现,用mTOR抑制剂激活自噬可刺激细胞内聚集的突变UMOD的清除。由于内质网应激介质TRIB3的表达增加,产生突变UMOD的人类细胞易受TNF-α和TRAIL介导的凋亡影响。用可溶性重组融合蛋白TNFR:Fc在体内阻断TNF-α可减缓UmodC147W/+小鼠的疾病进展,其机制是减少活性半胱天冬酶-3,从而防止肾小管细胞死亡和上皮功能丧失。这些发现揭示了UAKD相关疾病过程中的一种可靶向治疗的机制。